FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010245557> ?p ?o ?g. }

• W2010245557 endingPage "104" @default.
• W2010245557 startingPage "98" @default.
• W2010245557 abstract "Venous thromboembolism is a preventable cause of death in the severely injured patient. Low-molecular-weight heparins (LMWHs) have been recommended as effective, safe prophylactic agents. However, LMWH use remains controversial in patients at risk for bleeding, those with traumatic brain injury, and those undergoing multiple invasive or operative procedures. We hypothesized that a protocol utilizing once-daily LMWH prophylaxis in high-risk trauma patients, regardless of the need for invasive procedures, is feasible, safe, and effective. From August 1998 to August 2000, all patients admitted to our American College of Surgeons-verified Level I trauma facility following injury were evaluated for deep venous thrombosis (DVT) risk and prospectively followed. Patients at high risk for DVT, including those with stable intracranial injuries, were placed on our institutional protocol and prospectively followed. Patients on the protocol received daily injections of the LMWH, dalteparin; DVT screening was performed with duplex ultrasonography within 48 hours of admission and after 7 to 10 days after injury. Regimen compliance, bleeding complications, DVT rates, and pulmonary embolus (PE) rates were analyzed. During the 2-year study period, 6247 trauma patients were admitted; 743 were considered at high risk for DVT. Most of the patients were men (72%), with a mean age of 38.7 years (range 15–89 years) and a mean injury severity score (ISS) of 19.5. Compliance with the daily regimen was maintained in 74% of patients. DVT was detected in 3.9% and PE in 0.8%. The wound complications rate was 2.7%, and the need for unexplained transfusions was 3%. There were no exacerbations of head injury following dalteparin initiation due to bleeding. There were 16 patient deaths; none was caused by PE or late hemorrhage. Once-daily dosing of prophylactic LMWH dalteparin is feasible, safe, and effective in high-risk trauma patients. Our protocol allows one to “operate through” systemic prophylaxis and ensures timely prophylaxis for brain-injured and multisystem trauma patients." @default.
• W2010245557 created "2016-06-24" @default.
• W2010245557 creator A5034874268 @default.
• W2010245557 creator A5041612225 @default.
• W2010245557 creator A5057467043 @default.
• W2010245557 creator A5067320544 @default.
• W2010245557 date "2006-12-01" @default.
• W2010245557 modified "2023-09-27" @default.
• W2010245557 title "Utility of Once-Daily Dose of Low-Molecular-Weight Heparin to Prevent Venous Thromboembolism in Multisystem Trauma Patients" @default.
• W2010245557 cites W127034668 @default.
• W2010245557 cites W142041234 @default.
• W2010245557 cites W172556748 @default.
• W2010245557 cites W1972016137 @default.
• W2010245557 cites W1975952088 @default.
• W2010245557 cites W1988045314 @default.
• W2010245557 cites W1996451756 @default.
• W2010245557 cites W1999023440 @default.
• W2010245557 cites W2002622999 @default.
• W2010245557 cites W2022932023 @default.
• W2010245557 cites W2024553259 @default.
• W2010245557 cites W2024664415 @default.
• W2010245557 cites W2026954924 @default.
• W2010245557 cites W2037666435 @default.
• W2010245557 cites W2040548093 @default.
• W2010245557 cites W2051047426 @default.
• W2010245557 cites W2057034061 @default.
• W2010245557 cites W2059070394 @default.
• W2010245557 cites W2063313016 @default.
• W2010245557 cites W2067365123 @default.
• W2010245557 cites W2125302788 @default.
• W2010245557 cites W2130063291 @default.
• W2010245557 cites W2144319701 @default.
• W2010245557 cites W2150128639 @default.
• W2010245557 cites W2173538683 @default.
• W2010245557 cites W2321628844 @default.
• W2010245557 cites W2322068631 @default.
• W2010245557 cites W2324824914 @default.
• W2010245557 cites W2412312127 @default.
• W2010245557 cites W3148461121 @default.
• W2010245557 cites W4230738500 @default.
• W2010245557 cites W4235258250 @default.
• W2010245557 doi "https://doi.org/10.1007/s00268-006-0304-1" @default.
• W2010245557 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17180563" @default.
• W2010245557 hasPublicationYear "2006" @default.
• W2010245557 type Work @default.
• W2010245557 sameAs 2010245557 @default.
• W2010245557 citedByCount "74" @default.
• W2010245557 countsByYear W20102455572012 @default.
• W2010245557 countsByYear W20102455572013 @default.
• W2010245557 countsByYear W20102455572014 @default.
• W2010245557 countsByYear W20102455572015 @default.
• W2010245557 countsByYear W20102455572016 @default.
• W2010245557 countsByYear W20102455572017 @default.
• W2010245557 countsByYear W20102455572018 @default.
• W2010245557 countsByYear W20102455572019 @default.
• W2010245557 countsByYear W20102455572020 @default.
• W2010245557 countsByYear W20102455572021 @default.
• W2010245557 countsByYear W20102455572023 @default.
• W2010245557 crossrefType "journal-article" @default.
• W2010245557 hasAuthorship W2010245557A5034874268 @default.
• W2010245557 hasAuthorship W2010245557A5041612225 @default.
• W2010245557 hasAuthorship W2010245557A5057467043 @default.
• W2010245557 hasAuthorship W2010245557A5067320544 @default.
• W2010245557 hasBestOaLocation W20102455571 @default.
• W2010245557 hasConcept C141071460 @default.
• W2010245557 hasConcept C167135981 @default.
• W2010245557 hasConcept C188816634 @default.
• W2010245557 hasConcept C190385971 @default.
• W2010245557 hasConcept C194828623 @default.
• W2010245557 hasConcept C2776265017 @default.
• W2010245557 hasConcept C2776884760 @default.
• W2010245557 hasConcept C2780011451 @default.
• W2010245557 hasConcept C2780110798 @default.
• W2010245557 hasConcept C2780868729 @default.
• W2010245557 hasConcept C2781413609 @default.
• W2010245557 hasConcept C3017944768 @default.
• W2010245557 hasConcept C42219234 @default.
• W2010245557 hasConcept C71924100 @default.
• W2010245557 hasConcept C85004164 @default.
• W2010245557 hasConceptScore W2010245557C141071460 @default.
• W2010245557 hasConceptScore W2010245557C167135981 @default.
• W2010245557 hasConceptScore W2010245557C188816634 @default.
• W2010245557 hasConceptScore W2010245557C190385971 @default.
• W2010245557 hasConceptScore W2010245557C194828623 @default.
• W2010245557 hasConceptScore W2010245557C2776265017 @default.
• W2010245557 hasConceptScore W2010245557C2776884760 @default.
• W2010245557 hasConceptScore W2010245557C2780011451 @default.
• W2010245557 hasConceptScore W2010245557C2780110798 @default.
• W2010245557 hasConceptScore W2010245557C2780868729 @default.
• W2010245557 hasConceptScore W2010245557C2781413609 @default.
• W2010245557 hasConceptScore W2010245557C3017944768 @default.
• W2010245557 hasConceptScore W2010245557C42219234 @default.
• W2010245557 hasConceptScore W2010245557C71924100 @default.
• W2010245557 hasConceptScore W2010245557C85004164 @default.
• W2010245557 hasIssue "1" @default.
• W2010245557 hasLocation W20102455571 @default.
• W2010245557 hasLocation W20102455572 @default.
• W2010245557 hasOpenAccess W2010245557 @default.

• next